mRNA Cancer Vaccine Succeeds in Late-Stage Trial, Companies Say
Healthcare,MRNA,Vaccine,Cancer,Moderna,Merck
From the Right
AllSides Media Bias Rating: Lean Right
A cancer vaccine utilizing messenger ribonucleic acid (mRNA) technology prevented skin cancer from recurring in a phase 3 clinical trial, companies that make the vaccine said on Aug. 19.
The trial participants were people who underwent surgery to remove skin cancer.
The vaccine also prevented cancer from spreading in the patients, Moderna and Merck said.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
.jpg.webp)
